<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00097669</url>
  </required_header>
  <id_info>
    <org_study_id>ec550</org_study_id>
    <nct_id>NCT00097669</nct_id>
  </id_info>
  <brief_title>VITATOPS: A Study of VITAmins TO Prevent Stroke</brief_title>
  <official_title>VITATOPS - A Study of VITAmins TO Prevent Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VITATOPS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Health and Medical Research Council, Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Heart Foundation, Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical Health Research Infrastructure Council, Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VITATOPS</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The VITATOPS study is a multi-center, randomized, double blind, placebo-controlled secondary&#xD;
      stroke prevention trial to determine whether the addition of vitamin supplements (B12 500 ug,&#xD;
      B6 25 mg, Folate 2 mg) to best medical/surgical management (including modification of risk&#xD;
      factors) will reduce the combined incidence of recurrent vascular events (stroke, myocardial&#xD;
      infarction) and vascular death in patients with recent stroke or transient ischemic attack&#xD;
      (TIA). All patients presenting to one of the participating neurologists or general physicians&#xD;
      within seven months of stroke (ischemic or hemorrhagic) or TIA (eye or brain) are eligible&#xD;
      for this trial. Eligible patients will be randomized in a double-blind fashion to receive&#xD;
      multi-vitamins or placebo, 1 tablet daily. The primary outcome event is the composite event&#xD;
      &quot;stroke, myocardial infarction, or death from any vascular cause&quot;, whichever occurs first.&#xD;
      Our target is to recruit a total of 8,000 patients over the next two years with a median&#xD;
      follow-up of 2.5 years. Recruitment to the trial began in November 1998 and is planned to&#xD;
      continue until December 2005. We aim to complete final follow-up by the end of 2006. However,&#xD;
      the Steering Committee will be flexible in dictating the need for ongoing recruitment and&#xD;
      continuing follow-up, depending on the overall rate of the primary outcome event in the&#xD;
      entire cohort at each interim analysis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Epidemiological studies suggest that raised plasma concentrations of total&#xD;
      homocysteine (tHcy) may be a common, causal and treatable risk factor for&#xD;
      atherothromboembolic ischemic stroke, dementia and depression. Although tHcy can be lowered&#xD;
      effectively with small doses of folic acid, vitamin B12 and vitamin B6, it is not known&#xD;
      whether lowering tHcy, by means of multivitamin therapy, can prevent stroke and other major&#xD;
      atherothromboembolic vascular events, dementia and depression.&#xD;
&#xD;
      Purpose: To determine whether vitamin supplements (folic acid 2 mg, B6 25 mg, B12 500 ug)&#xD;
      reduce the risk of stroke, other serious vascular events, dementia and depression in patients&#xD;
      with recent stroke or transient ischemic attacks of the brain or eye (TIA).&#xD;
&#xD;
      Methods: An international, multi-center, randomized, double-blind, placebo-controlled&#xD;
      clinical trial.&#xD;
&#xD;
      Subjects: Patients with stroke or TIA in the previous 7 months.&#xD;
&#xD;
      Primary outcome measure: Non-fatal stroke, non-fatal myocardial infarction, or death due to&#xD;
      vascular causes.&#xD;
&#xD;
      Secondary outcome measures: TIA, Revascularisation procedures, Dementia, Depression.&#xD;
&#xD;
      Sample size calculation: To reliably identify a 15% reduction in relative risk of the primary&#xD;
      outcome event from 8% to 6.8% per year with an alpha of 0.05 and power of 80%, 8,000 patients&#xD;
      need to be randomized and followed-up for an average of two years.&#xD;
&#xD;
      Current progress: As of November, 2004, more than 4,400 patients have been randomized in 73&#xD;
      centers in 19 countries in five continents: Australia, Austria, Belgium, Brazil, Hong Kong,&#xD;
      Italy, Malaysia, Moldova, Netherlands, New Zealand, Pakistan, Philippines, Portugal, Republic&#xD;
      of Georgia, Serbia &amp; Monte Negro, Singapore, Sri Lanka, United Kingdom, and United States.&#xD;
&#xD;
      VITATOPS aims to recruit and follow up 8,000 patients between 2000 and 2006, and provide a&#xD;
      reliable estimate of the safety and effectiveness of dietary supplementation with folic acid,&#xD;
      vitamin B12, and vitamin B6 in reducing recurrent serious vascular events, dementia and&#xD;
      depression among a wide range of patients with stroke and TIA.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 1998</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Non-fatal Stroke, Non-fatal Myocardial Infarction or Death Due to Vascular Causes</measure>
    <time_frame>The primary outcome was measured over a median follow-up period of 3.4 years (interquartile range IQR 1.0-5.5 years).</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">8164</enrollment>
  <condition>Stroke</condition>
  <condition>Transient Ischemic Attack</condition>
  <arm_group>
    <arm_group_label>Active VITATOPS Tablet (folic acid 2mg, B6 25mg , B12 500ug)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active Treatment Arm: VITATOPS study tablet (folate 2 mg, B6 25 mg, B12 500 ug). Taken daily for the duration of the study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Tablet</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo Treatment Arm: The placebo tablet will have the same appearance, taste and texture as the vitamin preparation and contains excipients, coating and coating aids.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Active VITATOPS Tablet (folic acid 2mg, B6 25mg , B12 500ug) or placebo</intervention_name>
    <description>multivitamin</description>
    <arm_group_label>Active VITATOPS Tablet (folic acid 2mg, B6 25mg , B12 500ug)</arm_group_label>
    <other_name>VITATOPS study tablet</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo Tablet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients presenting within seven months of stroke (ischemic or hemorrhagic) or TIA&#xD;
&#xD;
          -  Agree to take study medication&#xD;
&#xD;
          -  Be geographically accessible for follow-up&#xD;
&#xD;
          -  Provide written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Taking folic acid or B6 on medical advice&#xD;
&#xD;
          -  Use of vitamin supplements containing folate, B6 or B12 (unless patient agrees to take&#xD;
             study medication instead of the vitamin supplements which they usually take)&#xD;
&#xD;
          -  Taking Methotrexate for any reason&#xD;
&#xD;
          -  Pregnancy or women of child-bearing potential who are at risk of pregnancy&#xD;
&#xD;
          -  Limited life expectancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Graeme Hankey, MBBS/MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Royal Perth Hospital / University of Western Australia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ross Baker, MBBS/BMedSc</last_name>
    <role>Study Director</role>
    <affiliation>Royal Perth Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Eikelboom, MBBS/FRACP</last_name>
    <role>Study Director</role>
    <affiliation>Royal Perth Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Konrad Jamrozik, MBBS</last_name>
    <role>Study Director</role>
    <affiliation>The University of Queensland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Frank van Bockxmeer, BSc/PhD</last_name>
    <role>Study Director</role>
    <affiliation>Royal Perth Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Siobhan Hickling, BSc/MPH</last_name>
    <role>Study Director</role>
    <affiliation>The University of Western Australia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anna Gelavis, BPharm</last_name>
    <role>Study Director</role>
    <affiliation>Royal Perth Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>JFK Hospital / Seton Hall University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Abington Memorial Hospital</name>
      <address>
        <city>Abington</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Carolina VA Hospital</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of South Carolina</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Coast Neuroscience Research</name>
      <address>
        <city>Gosford</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bankstown Hospital</name>
      <address>
        <city>New South Wales</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Hunter Hospital</name>
      <address>
        <city>New South Wales</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Liverpool Hospital</name>
      <address>
        <city>New South Wales</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Perth Hospital</name>
      <address>
        <city>Perth</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greenslopes Hospital</name>
      <address>
        <city>Queensland</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nambour Hospital</name>
      <address>
        <city>Queensland</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Flinders &amp; Griffiths</name>
      <address>
        <city>South Australia</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Hobart Hospital</name>
      <address>
        <city>Tasmania</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alfred Hospital</name>
      <address>
        <city>Victoria</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beleura &amp; Frankston Hospital</name>
      <address>
        <city>Victoria</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Box Hill Hospital</name>
      <address>
        <city>Victoria</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Stroke Research Institute - Austin Health</name>
      <address>
        <city>Victoria</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fremantle Hospital</name>
      <address>
        <city>Western Australia</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Joondalup Hospital</name>
      <address>
        <city>Western Australia</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sir Charles Gairdner Hospital</name>
      <address>
        <city>Western Australia</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karl-Franzens University Graz</name>
      <address>
        <city>Graz</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Algemeen Ziekenhuis Sint-Jan Autonome Verzorgingsinstelling</name>
      <address>
        <city>Brugge</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universidade Federal Fluminense &amp; Universidade Federal do Rio de Janeiro</name>
      <address>
        <city>Rio de Janeiro</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sarajishvili Institute of Neurology and Neurosurgery</name>
      <address>
        <city>Tbilisi</city>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Mary Hospital</name>
      <address>
        <city>Pokfulam</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prince of Wales Hospital</name>
      <address>
        <city>Shatin</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rajah Muthaiah Medical College</name>
      <address>
        <city>Annamalainagar</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St John's Medical College Hospital</name>
      <address>
        <city>Bangalore</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SP Medical College</name>
      <address>
        <city>Bikaner</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baby Memorial Hospital</name>
      <address>
        <city>Calicut</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KS Hospital</name>
      <address>
        <city>Chennai</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amrita Institute of Medical Science</name>
      <address>
        <city>Cochin</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Care Hopstial</name>
      <address>
        <city>Hyderabad</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mahaveer Hospital &amp; Research Centre</name>
      <address>
        <city>Hyderabad</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mediciti Hospital</name>
      <address>
        <city>Hyderabad</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MGM Medical College &amp; MY Hospital</name>
      <address>
        <city>Indore</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Monilek Hospital</name>
      <address>
        <city>Jaipur</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centauri, The Albert Road Clinic</name>
      <address>
        <city>Kolkata</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CSMMU</name>
      <address>
        <city>Lucknow</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christian Medical College &amp; Hospital</name>
      <address>
        <city>Ludhiana</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>G.B. Pant Hospital</name>
      <address>
        <city>New Delhi</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sir Ganga Ram Hospital</name>
      <address>
        <city>New Delhi</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sadhbavana Medical &amp; Heart Institute</name>
      <address>
        <city>Patiaala</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Railway Hospital</name>
      <address>
        <city>Perambur</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Poona Hospital</name>
      <address>
        <city>Pune</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ruby Hall Clinic</name>
      <address>
        <city>Pune</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neurocenter</name>
      <address>
        <city>Trichy</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Care Hospital</name>
      <address>
        <city>Visakhapatnam</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mahatma Gandhi Institute</name>
      <address>
        <city>Wardha</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spedali Civili Di Brescia</name>
      <address>
        <city>Brescia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale di Circolo de Busto Arsizio</name>
      <address>
        <city>Busto Arsizio</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale di Macerata</name>
      <address>
        <city>Macerata</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IRCCS Fondazione Istituto Neurologico C Mondino</name>
      <address>
        <city>Pavia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Perugia Stroke Service &amp; Citta Della Peive</name>
      <address>
        <city>Perugia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Perugia</name>
      <address>
        <city>Perugia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale R Guzzardi</name>
      <address>
        <city>Vittoria</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universiti Sains Malaysia</name>
      <address>
        <city>Kelantan</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Malaya Medical Centre</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City Emergency Hospital</name>
      <address>
        <city>Chishinau</city>
        <country>Moldova, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Slotervaartziekenhuis</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oosterscheldeziekenhuis</name>
      <address>
        <city>Goes</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Utrecht</name>
      <address>
        <city>Utrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Auckland Hospital</name>
      <address>
        <city>Auckland</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hawkes Bay Hospital</name>
      <address>
        <city>Hastings</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Palmerston North Hospital</name>
      <address>
        <city>Palmerston North</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore Hospital</name>
      <address>
        <city>Takapuna</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wellington Hospital</name>
      <address>
        <city>Wellington South</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KRL University</name>
      <address>
        <city>Islamabad</city>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pakistan Institute of Medical Sciences</name>
      <address>
        <city>Islamabad</city>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DUHS - Civil Hospital</name>
      <address>
        <city>Karachi</city>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DUHS - Jinnah Hospital</name>
      <address>
        <city>Karachi</city>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>POF Hospital Wah Cantt.</name>
      <address>
        <city>Wah Cantt</city>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cagayan de Oro Medical Center</name>
      <address>
        <city>Cebu City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cebu Doctor's Hospital</name>
      <address>
        <city>Cebu City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cebu Velez General Hospital/ Visayas Comm. Medical Center</name>
      <address>
        <city>Cebu City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chong Hua Hospital</name>
      <address>
        <city>Cebu City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vicente Sotto Memorial Hospital</name>
      <address>
        <city>Cebu City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cagayan Valley Medical Center</name>
      <address>
        <city>East Santiago City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jose R Reyes Memorial Medical Centre</name>
      <address>
        <city>Manila</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Santo Tomas Hospital</name>
      <address>
        <city>Manila</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Visconde de Salreu</name>
      <address>
        <city>Estarreja</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Santa Maria</name>
      <address>
        <city>Lisboa</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Distrital de Oliverira de Azemeis</name>
      <address>
        <city>Oliveira de Azemeis</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Geral de Santo Antonio</name>
      <address>
        <city>Porto</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Novi Sad - Neurology &amp; Neurosurgery</name>
      <address>
        <city>Novisad</city>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Singapore General Hospital</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital of Sri Lanka</name>
      <address>
        <city>Colombo</city>
        <country>Sri Lanka</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kelaniya</name>
      <address>
        <city>Ragama</city>
        <country>Sri Lanka</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of North Staffordshire</name>
      <address>
        <city>Stoke on Trent</city>
        <state>Shaffordshire</state>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aberdeen Royal Infirmary</name>
      <address>
        <city>Aberdeen</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Redbridge Health Care</name>
      <address>
        <city>Barking</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barnsley District Hospital</name>
      <address>
        <city>Barnsley</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Royal Victoria Hospital</name>
      <address>
        <city>Belfast</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bronglais General Hospital</name>
      <address>
        <city>Ceredigion</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Western General Hospital, Edinburgh</name>
      <address>
        <city>Edinburgh</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Devon &amp; Exeter Hospital</name>
      <address>
        <city>Exeter</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Western Infirmary</name>
      <address>
        <city>Glasgow</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Luke's Hospital</name>
      <address>
        <city>Huddersfield</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Harvey Hospital</name>
      <address>
        <city>Kent</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Aintree</name>
      <address>
        <city>Liverpool</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Altnagelvin Hospital</name>
      <address>
        <city>Londonderry</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Luton and Dunstable Hospital</name>
      <address>
        <city>Luton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Victoria Infirmary, Newcastle</name>
      <address>
        <city>Newcastle</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Tyneside District General Hospital</name>
      <address>
        <city>North Shields</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nottingham City Hospital</name>
      <address>
        <city>Nottingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Mary's Paddington Hospital</name>
      <address>
        <city>Paddington</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rotherham General Hospital</name>
      <address>
        <city>Rotherham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stirling Royal Infirmary</name>
      <address>
        <city>Stirling</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stepping Hill Hospital</name>
      <address>
        <city>Stockport</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Musgrove Park Hosptial</name>
      <address>
        <city>Taunton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Torbay Hospital</name>
      <address>
        <city>Torquay</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Georgia</country>
    <country>Hong Kong</country>
    <country>India</country>
    <country>Italy</country>
    <country>Malaysia</country>
    <country>Moldova, Republic of</country>
    <country>Netherlands</country>
    <country>New Zealand</country>
    <country>Pakistan</country>
    <country>Philippines</country>
    <country>Portugal</country>
    <country>Serbia</country>
    <country>Singapore</country>
    <country>Sri Lanka</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Former Serbia and Montenegro</country>
    <country>Former Yugoslavia</country>
  </removed_countries>
  <link>
    <url>http://www.heartfoundation.com.au/</url>
    <description>National Heart Foundation</description>
  </link>
  <link>
    <url>http://www.strokefoundation.com.au/</url>
    <description>National Stroke Foundation</description>
  </link>
  <link>
    <url>http://www.strokesociety.com.au/</url>
    <description>Stroke Society of Australasia Inc.</description>
  </link>
  <verification_date>January 2014</verification_date>
  <study_first_submitted>November 24, 2004</study_first_submitted>
  <study_first_submitted_qc>November 24, 2004</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2004</study_first_posted>
  <results_first_submitted>January 20, 2014</results_first_submitted>
  <results_first_submitted_qc>September 7, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 25, 2020</results_first_posted>
  <last_update_submitted>September 7, 2020</last_update_submitted>
  <last_update_submitted_qc>September 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>VITATOPS</keyword>
  <keyword>stroke</keyword>
  <keyword>prevention</keyword>
  <keyword>multivitamins</keyword>
  <keyword>homocysteine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Attack, Transient</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Folic Acid</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Active VITATOPS Tablet (Folic Acid 2mg, B6 25mg , B12 500ug)</title>
          <description>Active Treatment Arm: VITATOPS study tablet (folate 2 mg, B6 25 mg, B12 500 ug). Taken daily for the duration of the study.&#xD;
Active VITATOPS Tablet (folic acid 2mg, B6 25mg , B12 500ug): multivitamin</description>
        </group>
        <group group_id="P2">
          <title>Placebo Tablet</title>
          <description>Placebo Treatment Arm: The placebo tablet will have the same appearance, taste and texture as the vitamin preparation and contains excipients, coating and coating aids.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4089"/>
                <participants group_id="P2" count="4075"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4089"/>
                <participants group_id="P2" count="4075"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Active VITATOPS Tablet (Folic Acid 2mg, B6 25mg , B12 500ug)</title>
          <description>Active Treatment Arm: VITATOPS study tablet (folate 2 mg, B6 25 mg, B12 500 ug). Taken daily for the duration of the study.&#xD;
Active VITATOPS Tablet (folic acid 2mg, B6 25mg , B12 500ug): multivitamin</description>
        </group>
        <group group_id="B2">
          <title>Placebo Tablet</title>
          <description>Placebo Treatment Arm: The placebo tablet will have the same appearance, taste and texture as the vitamin preparation and contains excipients, coating and coating aids.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="4089"/>
            <count group_id="B2" value="4075"/>
            <count group_id="B3" value="8164"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62.5" spread="12.6"/>
                    <measurement group_id="B2" value="62.6" spread="12.4"/>
                    <measurement group_id="B3" value="62.6" spread="12.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1475"/>
                    <measurement group_id="B2" value="1471"/>
                    <measurement group_id="B3" value="2946"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2614"/>
                    <measurement group_id="B2" value="2604"/>
                    <measurement group_id="B3" value="5218"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Functional severity of qualifying stroke</title>
          <description>Oxford Handicap Score (&lt;3 = functionally independent; 3-5= functional dependent on help)</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Independent (Oxford handicap score 0-3)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3035"/>
                    <measurement group_id="B2" value="3024"/>
                    <measurement group_id="B3" value="6059"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dependent (Oxford handicap score 3,4 or 5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="951"/>
                    <measurement group_id="B2" value="943"/>
                    <measurement group_id="B3" value="1894"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>past history of stroke, prior to qualifying stroke or transient ischemic attack (TIA)</title>
          <description>This measure refers to the number of randomised patients who had a history of a previous stroke, prior to the stroke or transient ischemic attack (TIA) that qualified them for entry into the trial.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="624"/>
                    <measurement group_id="B2" value="658"/>
                    <measurement group_id="B3" value="1282"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>laboratory results for fasting homocysteine</title>
          <description>Fasting blood homocysteine concentrations were measured and expressed in micromoles per litre</description>
          <units>micromoles per liter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14.4" spread="9.2"/>
                    <measurement group_id="B2" value="14.2" spread="7.7"/>
                    <measurement group_id="B3" value="14.3" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Non-fatal Stroke, Non-fatal Myocardial Infarction or Death Due to Vascular Causes</title>
        <time_frame>The primary outcome was measured over a median follow-up period of 3.4 years (interquartile range IQR 1.0-5.5 years).</time_frame>
        <population>Intention to treat analysis population of all patients randomised (n=8164)</population>
        <group_list>
          <group group_id="O1">
            <title>Active VITATOPS Tablet (Folic Acid 2mg, B6 25mg , B12 500ug)</title>
            <description>Active Treatment Arm: VITATOPS study tablet (folate 2 mg, B6 25 mg, B12 500 ug). Taken daily for the duration of the study.&#xD;
Active VITATOPS Tablet (folic acid 2mg, B6 25mg , B12 500ug): multivitamin</description>
          </group>
          <group group_id="O2">
            <title>Placebo Tablet</title>
            <description>Placebo Treatment Arm: The placebo tablet will have the same appearance, taste and texture as the vitamin preparation and contains excipients, coating and coating aids.</description>
          </group>
        </group_list>
        <measure>
          <title>Non-fatal Stroke, Non-fatal Myocardial Infarction or Death Due to Vascular Causes</title>
          <population>Intention to treat analysis population of all patients randomised (n=8164)</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4089"/>
                <count group_id="O2" value="4075"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="616"/>
                    <measurement group_id="O2" value="678"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>We used Kaplan-Meier methods to construct cumulative time-to-event curves for the two groups, with a comparison by use of the log-rank test.&#xD;
We used a Cox proportional hazard model analysis to control for any potential imbalance in baseline characteristics and follow-up between the two groups.</non_inferiority_desc>
            <p_value>0.05</p_value>
            <method>Log Rank</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.91</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.82</ci_lower_limit>
            <ci_upper_limit>1.00</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>Regression, Cox</method>
            <method_desc>Analysis before adjusting for any potential imbalance in the baseline characteristics and follow-up duration between the groups.</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.90</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.81</ci_lower_limit>
            <ci_upper_limit>1.00</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>Regression, Cox</method>
            <method_desc>Analysis after adjusting for any potential imbalance in the baseline characteristics and follow-up duration between the groups.</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.91</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.81</ci_lower_limit>
            <ci_upper_limit>1.03</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Active VITATOPS Tablet (Folic Acid 2mg, B6 25mg , B12 500ug)</title>
          <description>Active Treatment Arm: VITATOPS study tablet (folate 2 mg, B6 25 mg, B12 500 ug). Taken daily for the duration of the study.&#xD;
Active VITATOPS Tablet (folic acid 2mg, B6 25mg , B12 500ug): multivitamin</description>
        </group>
        <group group_id="E2">
          <title>Placebo Tablet</title>
          <description>Placebo Treatment Arm: The placebo tablet will have the same appearance, taste and texture as the vitamin preparation and contains excipients, coating and coating aids.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4089"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4075"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4089"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4075"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Trial Coordinator</name_or_title>
      <organization>VITATOPS</organization>
      <phone>+61892247004</phone>
      <email>julia.o'dea@health.wa.gov.au</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

